STELLA PHARMA NEWS
BNCT
May 9th, 2024

BNCT Project in Hong Kong-Shenzhen – Memorandum of Understanding signing ceremony

Together with China Biotech Services Holdings Limited (CBSH), our partner for t……

READ MORE

April 16th, 2024

Paper published: Clinical trial about Boron Neutron Capture Therapy for recurrent breast cancer

Our company provides Steboronine® for the investigator-initiated specified clin……

READ MORE

March 29th, 2024

Published in “Nature” – Article about our Company and BNCT

The international science journal “Nature” published in its special edition “Ra……

READ MORE

March 4th, 2024

Interim Analysis Results of Post-Marketing Surveillance of Our Drug Product published ― Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer

The results regarding safety and effectiveness of our product Borofalan(10B), u……

READ MORE

January 11th, 2024

Investigator-initiated Phase I BNCT clinical trial for newly diagnosed glioblastoma

We would like to announce that Phase I clinical trial for newly diagnosed gliob……

READ MORE

December 25th, 2023

Orphan Drug designation for Borofalan (10B) (SPM-011) as treatment of Cutaneous Angiosarcoma

Angiosarcoma is a kind of cancer that is derived from vascular endothelial cell……

READ MORE

December 13th, 2023

Stella Pharma, Mitsubishi Chemical Group, and the University of Tokyo conclude Joint Research Agreement—Accelerating practical application of polyvinyl alcohol (PVA) for boron neutron capture therapy (BNCT)—

Stella Pharma Corporation , Mitsubishi Chemical Corporation of the Mitsubishi C……

READ MORE

December 6th, 2023

Encounter with Director of Cancer Research Center of Lyon, and Team of Centre Léon Bérard at French Embassy

Business France Japan Office of the French Embassy in Japan engages in building……

READ MORE

June 24th, 2022

Notice Regarding Our First Overseas Introduction of BNCT in the Hainan Medical Tourism Pilot Zone, China

Sumitomo Heavy Industries, Ltd. and STELLA PHARMA CORPORATION have respectively……

READ MORE

February 18th, 2022

“Destroying Cancer with Boron and Neutrons” will be on NHK WORLD-JAPAN

Japan's public media organization NHK (Japan Broadcasting Corporation) will bro……

READ MORE

October 21st, 2021

Interview published on Science Japan, online magazine| Japan’s “Fifth Cancer Treatment,” BNCT, Finally Off the Ground

Here is a featured story on BNCT (Boron Neutron Capture Therapy) boron drug dev……

READ MORE

June 23rd, 2021

The phase II study of recurrent glioblastoma in Japan has published in “Neuro-Oncology Advances”

The title is “Accelerator-based BNCT for patients with recurrent glioblastoma: ……

READ MORE